Cancer-fighting biotech takes step closer to being Bay Area’s third IPO of the year
April 20, 2020 at 10:37 AM EDT
The South San Francisco cancer-focused biotech hopes to raise up to $92 million in an offering that would value the business as high as about $368 million.